CKD Bio Corp
KRX:063160

Watchlist Manager
CKD Bio Corp Logo
CKD Bio Corp
KRX:063160
Watchlist
Price: 20 350 KRW Market Closed
Market Cap: 111.7B KRW

Intrinsic Value

The intrinsic value of one CKD Bio Corp stock under the Base Case scenario is 20 953.69 KRW. Compared to the current market price of 20 350 KRW, CKD Bio Corp is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
20 953.69 KRW
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CKD Bio Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about CKD Bio Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CKD Bio Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CKD Bio Corp.

Explain Valuation
Compare CKD Bio Corp to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CKD Bio Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CKD Bio Corp

Current Assets 115.2B
Cash & Short-Term Investments 1.2B
Receivables 31.3B
Other Current Assets 82.8B
Non-Current Assets 169.3B
Long-Term Investments 2B
PP&E 159.2B
Intangibles 6.5B
Other Non-Current Assets 1.7B
Current Liabilities 90.7B
Accounts Payable 6B
Accrued Liabilities 5.9B
Short-Term Debt 59.4B
Other Current Liabilities 19.4B
Non-Current Liabilities 62.8B
Long-Term Debt 60.3B
Other Non-Current Liabilities 2.5B
Efficiency

Free Cash Flow Analysis
CKD Bio Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CKD Bio Corp

Revenue
159B KRW
Cost of Revenue
-126B KRW
Gross Profit
33.1B KRW
Operating Expenses
-25.3B KRW
Operating Income
7.7B KRW
Other Expenses
-5.9B KRW
Net Income
1.9B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

CKD Bio Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Operating Margin is Increasing
Net Margin is Increasing
42/100
Profitability
Score

CKD Bio Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CKD Bio Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Low D/E
Average Altman Z-Score
33/100
Solvency
Score

CKD Bio Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CKD Bio Corp

There are no price targets for CKD Bio Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CKD Bio Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CKD Bio Corp stock?

The intrinsic value of one CKD Bio Corp stock under the Base Case scenario is 20 953.69 KRW.

Is CKD Bio Corp stock undervalued or overvalued?

Compared to the current market price of 20 350 KRW, CKD Bio Corp is Undervalued by 3%.

Back to Top